NSECertificate under SEBI (Depositories and Participants) Regulations, 20188 Jul 2026 · 8 Jul 2026, 10:48 am

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Panacea Biotec Limited · PANACEABIO

✦ AI Summary

Panacea Biotec Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming compliance with Regulation 74(5) for the quarter ended June 30, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Panacea Biotec Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Attachments (1)

📄

PANACEABIO_08072026104825_CertificateUnder74_5_.pdf

pdf

Download →
View document text
July 07, 2026 The Manager, Listing Department BSE Limited The National Stock Exchange of India Ltd. Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai - 400 051 Dalal Street, Mumbai - 400 001 NSE Symbol: PANACEABIO BSE Scrip Code: 531349 Sub: Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participant) Regulations, 2018 for the quarter ended June 30, 2026 Dear Sir, We are enclosing herewith a certificate dated July 01, 2026, issued by Skyline Financial Services Private Limited, Registrar and Transfer Agent of the Company, confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026. This is for your kind information and record please. Thanking you, Sincerely yours, for Panacea Biotec Limited Ankit Jain General Manager – Legal & Company Secretary Encl. As above Panacea Biotec Ltd (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn./A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Email: companysec@panaceabiotec.com Skyline Financial Services Pvt. Ltd. Sk line SEBI Registered Category-1 Registrars & Share Transfer Agent Financial )!rvices Pvt. Ltd. Regd. & Corp. Office: D-153 A, 1st Floor, Okhla Industrial Area, Phase-I, New Delhi -110 020 Tel.: +91-11-40450193-97, 26812682-83, E-mail: info@skyllnerta.com, Website: www.skylinerta.com CIN No.: U74899DL1995PTC071324 Odled. Joly 01, ?O?e Ref:SFSPL/RTA/June/2026 The Company Secretary PANACEA BIOTEC LIMITED B-1 EXTN A-27 MOHAN CO-OPERATIVE INDUSTRIAL ESTAT MATHURA ROAD BADARPUR NEW DELHI 110044 Subject: Confirmation Certificate in the matter of Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. Dear Sir, In accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 30th June, 2026, w.r.t. physical share certificates received for dematerialization of securities from the depository participant (Equity Shares) of the Company, " PANACEA BIOTEC LIMITED " CIN: L33117PB1984PLC022350. We hereby confirm and certify the following: a) The securities comprised in the said certificate(s) have been listed on the Stock Exchange where the earlier issued securities are listed: b) The said certificate(s) after due verification have been mutilated and cancelled and the name of depository has been substituted in our records as registered owner within ~5 days. This is for your information and records. Thanking you, Mumbai Office: A-506, Dattani Plaza, Andheri Kurla Road, Safeed Pool, Mumbai-400072 Tel.: +91-22-49721245, 28511022, E-mail: mumbai@skylinerta.com